Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1988 Aug;32(8):1292–1293. doi: 10.1128/aac.32.8.1292

Double-blind, randomized comparison of 24 weeks of norfloxacin and 12 weeks of norfloxacin followed by 12 weeks of placebo in the therapy of complicated urinary tract infection.

G J Sheehan 1, G K Harding 1, D A Haase 1, M J Thomson 1, B Urias 1, J K Kennedy 1, D J Hoban 1, A R Ronald 1
PMCID: PMC172398  PMID: 3056259

Abstract

We evaluated the benefits of prolonging norfloxacin therapy from 12 to 24 weeks for complicated urinary tract infection in a double-blind, randomized, placebo-controlled study. During the second 12 weeks, norfloxacin was superior to placebo (P less than 0.05) in suppressing bacteriuria. Adverse effects were common but mostly confined to the initial 12 weeks.

Full text

PDF
1292

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chinn R. H., Maskell R., Mead J. A., Polak A. Renal stones and urinary infection: a study of antibiotic treatment. Br Med J. 1976 Dec 11;2(6049):1411–1413. doi: 10.1136/bmj.2.6049.1411. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Freeman R. B., Smith W. M., Richardson J. A., Hennelly P. J., Thurm R. H., Urner C., Vaillancourt J. A., Griep R. J., Bromer L. Long-term therapy for chronic bacteriuria in men. U.S. Public Health Service cooperative study. Ann Intern Med. 1975 Aug;83(2):133–147. doi: 10.7326/0003-4819-83-2-133. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES